Tasimelteon (trade name Hetlioz) is a drug approved by the FDA solely for the treatment of non-24-hour sleep–wake disorder (often designated as N24HSWD) in totally blind adults. It is a selective agonist for the melatonin receptors MT1 and MT2 in the suprachiasmatic nucleus of the brain, similar to other members of the melatonin receptor agonist class of which ramelteon (2005) and agomelatine (2009) were the first approved.
The Smallest Drugs Here is the updated version of the "smallest drugs" collection that I did the other day. Here are the criteria I used: the molecular weight cutoff was set, arbitrarily, at aspirin's 180. I excluded the inhaled anaesthetics, only allowing things that are oils or solids in their form of use. As a small-molecule organic chemist, I only allowed organic compounds - lithium and so on are for another category
Open Access Plus ::: Recent Patents on Anti-Cancer Drug Discovery
Open Access Plus ::: Recent Patents on Anti-Cancer Drug Discovery Circulatory Estrogen Level Protects Against Breast Cancer in Obese Women Zsuzsanna Suba #benthamscience #benthamsciencepublishers www.benthamscience.com www.recentpatentsonanticancerdrugdiscovery.com